Epigenetic modifications: basic mechanisms and role in cardiovascular disease. - Test2 - elhamkhani - TriplyDB

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

http://www.wikidata.org/entity/Q27693287

about

Epigenetics in heart failure phenotypes Insulin-like growth factors and their potential role in cardiac epigenetics Epigenetic associations in relation to cardiovascular prevention and therapeutics DNA modifications: function and applications in normal and disease States Epigenetic mechanisms underlying cardiac degeneration and regeneration Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications Genetics of coronary artery disease Clinical applications of epigenetics in cardiovascular disease: the long road ahead O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?Epigenetic regulation of Keap1-Nrf2 signaling Epigenetic Regulation in Particulate Matter-Mediated Cardiopulmonary Toxicities: A Systems Biology Perspective Mitochondrial health, the epigenome and healthspan Computational Analysis and Predictive Cheminformatics Modeling of Small Molecule Inhibitors of Epigenetic Modifiers Disturbance of cardiac gene expression and cardiomyocyte structure predisposes Mecp2-null mice to arrhythmias Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy.Microfluidics for genome-wide studies involving next generation sequencing.Protein arginine hypomethylation in a mouse model of cystathionine β-synthase deficiency.Oligodeoxynucleotides Can Transiently Up- and Downregulate CHS Gene Expression in Flax by Changing DNA Methylation in a Sequence-Specific Manner.Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series).Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes.Notable epigenetic role of hyperhomocysteinemia in atherogenesis.Protein arginine methylation is more prone to inhibition by S-adenosylhomocysteine than DNA methylation in vascular endothelial cells.The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine.Genome-wide identification of long noncoding RNAs in rat models of cardiovascular and renal disease The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions.Epigenetic mechanisms of pulmonary hypertension.Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cells.Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study The role of epigenetics in spermatogenesis.Identification and Structure-Activity Relationship Studies of Small-Molecule Inhibitors of the Methyllysine Reader Protein Spindlin1.The role of redox signaling in epigenetics and cardiovascular disease.Selenistasis: epistatic effects of selenium on cardiovascular phenotype.SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together The Mechanobiology of Aging Methoxistasis: integrating the roles of homocysteine and folic acid in cardiovascular pathobiology.Genetics and epigenetics of arrhythmia and heart failure.Malondialdehyde mediates oxidized LDL-induced coronary toxicity through the Akt-FGF2 pathway via DNA methylation.In vitro analysis of factors influencing CYP1A2 expression as potential determinants of interindividual variation.Epigenetics and chromatin remodeling in adult cardiomyopathy.Recent advances in the bioanalysis of modified nucleotides in epigenetic studies.

P2860

Q26747565-505E6F38-175D-49B3-A7BB-A2C8981BAC62 Q26750525-857392FC-2B63-4D33-A6DB-2EC087F9D99B Q26771428-BF4F43B9-F32E-4F61-9372-6FABE3B25AC0 Q26829214-E230EEB8-6856-46DB-9441-DD1DF6053478 Q26853220-2A807309-44C6-4D3F-8B87-E82323AA8131 Q26859263-0A2D2329-977B-45F6-A0EA-89CEE258A720 Q26866396-B8575DD0-868A-4AAF-8E58-48857DFCBD0E Q27008290-E56996DF-6D6A-41DC-97B7-45D91BBE5791 Q27693206-042A67E7-4D1B-4D87-99A8-DE77C82F1808 Q28084220-1654E332-E780-4DB0-AFFD-CFE5292DF012 Q28391305-346CF789-9695-4DBD-84FF-33278E0CC30E Q28391740-332BBF7F-FAD7-419A-A35E-AB4CDBDA1BF5 Q28554035-6F3F0DEF-AC3C-4631-9E6E-A3C6FB800AF6 Q28648466-01AE1386-B47F-4041-B8FE-90DE07BE3846 Q30234440-C5979D57-53E1-4D3F-8053-153C21D2AC9E Q30359014-62679592-B7C1-4B14-90F1-125C68873840 Q33613244-FF1565B0-0B0F-47DD-9441-FCB01FADDD3B Q33679370-CBFFF20C-AE66-4C5B-AC9A-C435C8728565 Q33806018-22439374-38EC-4ECE-B730-DC3B18B51BB8 Q34099937-69260AEA-79ED-4918-B968-665823685D89 Q34143826-6FF136A1-D8E7-414A-B56B-84DF6D59240C Q34586093-B59F20F2-C1DE-470E-AFE4-51C166C7D934 Q34755672-4C026C2B-9876-42E9-9222-4661D4B71242 Q35146760-BBA607A0-17C0-42BA-BBD3-00AC3567A2DD Q35540524-39D533EA-0A3F-4B35-B97A-663CDE2AA9C1 Q35573935-96978C73-4746-4917-A2D9-454044AB3A6E Q35690674-BCBFF9B8-64A5-4892-A75A-936B2992E181 Q35826444-B0D18BCF-FEF5-4684-80AA-9B52BD0EFDBF Q35993946-03B3D89C-4465-42E7-A759-7700208A283F Q36135192-0A0C2EB1-2F55-4070-B84B-E7F63B5B751C Q36761147-46D3E4EB-C0D5-484D-B840-AF126A983D42 Q36792384-A7C6F822-803A-45FA-BD22-C5129099BB98 Q36867464-84F479CB-CD54-4FC1-9DC0-E87E406DAC65 Q36949552-F1FCED50-CBCD-45DA-B700-07A937CEC93F Q37177422-EE2D028D-9228-4400-B154-970BB4B8363B Q37267318-48347789-E376-4BF4-A439-9379F42680E4 Q37596872-485122DC-14FE-4F80-AD84-CC11E4018B06 Q37724295-25373094-DB4B-4444-8604-5A6B11A8CE10 Q38118214-02DA5F60-D16B-42C3-844D-E3B9129088A6 Q38167832-0597F80A-67DF-462E-8654-E9652E13A2B4

P2860

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

http://www.wikidata.org/entity/Q27693287

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

@ast

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

@en

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

@nl

type

label

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

@ast

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

@en

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

@nl

prefLabel

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

@ast

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

@en

Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

@nl

P1433

Q27693287-5504FC82-FCD7-402F-9E04-16C931C0F2E6

P1476

Q27693287-C1421BFA-5659-4D31-8416-FD5DFD9435AE

P2093

Q27693287-AC63784D-EB01-4C3A-A540-03507029F3FC

Q27693287-E248B4BD-83DD-438D-A244-202BDBA187E5

P2860

Q27693287-000DC076-0025-4370-8B36-FBE318F54F69

Q27693287-00D5DF60-B528-4D7A-8920-B8E3FB0805F8

Q27693287-060C0381-6837-45CA-8375-460315BFD940

Q27693287-091C7AB6-7DCC-4103-85A9-49BF8BB105F5

Q27693287-0C470412-B455-420A-88CB-E4AF29296D9F

Q27693287-0E582B64-3638-4050-93C4-74301005E9A0

Q27693287-0E63770F-6BBC-40EB-BB7D-C21C2C1CC9F5

Q27693287-1163B44B-AEEA-479E-B56A-10100652A744

Q27693287-1302257A-D5EA-414C-9471-69FEA850124B

Q27693287-1311CC7B-1EA2-47F6-8099-8DF8E0E5BA14

P304

Q27693287-BE785998-2F2C-43C7-AF00-8B72B0EBA0C5

P31

Q27693287-A896676F-84B1-44BE-8030-FDBC050C8664

P3181

Q27693287-811B4D87-D598-4AA4-8AB7-718F90ED2FA5

P356

Q27693287-2D72EF10-ECB2-4E6F-B1FC-876F5C30369B

P407

Q27693287-E11063D5-D0FA-4374-94F0-B8CB796DA61C

P433

Q27693287-976A2855-9B88-439A-9212-41BC31D05C20

P478

Q27693287-A2A15F87-58EF-463C-A3EA-02213E133E1B

P50

Q27693287-3BC1A5AF-2688-4545-AD58-6127C955379F

P577

Q27693287-B1324E24-E088-4986-94D9-D34027708A9F

P698

Q27693287-8FDC9106-302F-4649-803F-FF542D5BEFA0

P921

Q27693287-A574BA6A-4FBE-4D23-9689-5596C1D36C96

P932

Q27693287-8A4E75FD-3634-487B-93A7-9C4A2E89F45D

P3181

P356

CIRCULATIONAHA.110.956839

P1433

P1476

Epigenetic modifications: basic mechanisms and role in cardiovascular disease

@en

P2093

Joseph Loscalzo

http://www.w3.org/2001/XMLSchema#string

Rita Castro

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of a family of mammalian methyl-CpG binding proteins

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

Translating the Histone Code

Finding the missing heritability of complex diseases

KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints

LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription

JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor

Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

Epigenetic differences arise during the lifetime of monozygotic twins

P304

2145-2156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1208658

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/CIRCULATIONAHA.110.956839

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21576679

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

3107542

http://www.w3.org/2001/XMLSchema#string